Paeds Vivas · child-safety-and-social-paediatrics
Youth justice and detained young people — viva
Branching structured oral on the health of justice-involved and detained young people: the equivalence-of-care principle, the entry-screening pathway, the clustered health needs, suicide and self-harm risk, neurodisability, consent and confidentiality in custody, the post-release mortality spike, and the advocacy role.
branching clinical structured oral
On this page & tools
Target exams
RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A 16-year-old boy is seen on his first night in remand detention after disclosing suicidal thoughts. The candidate must explain the equivalence-of-care principle, the acute suicide and self-harm risk assessment, the entry health screen, the recognition of neurodisability, the consent and confidentiality issues in custody, and the release health plan.
Opening
The examiner presents a 16-year-old boy seen on his first night in remand detention after disclosing suicidal thoughts during the reception screen. He has a history of school exclusion, prenatal alcohol exposure and a four-month gap in community mental-health contact. The candidate is asked to outline the approach to his health care. [1] [5]
Branch 1 — The guiding principle
- What principle frames your duty to this young person, and what does it require? Lead with equivalence of care: the standard, range and quality of health care in detention must match the community, as the UN Havana Rules and national bodies require. [1] [16]
- How does that principle change the way you prioritise tonight? The acute risk takes precedence — suicide and self-harm, intoxication and withdrawal. [5] [11]
Branch 2 — Acute risk assessment and management
- Walk through your suicide and self-harm risk assessment in the first 24–72 hours. Explicit risk assessment, observation level, removal of means, supportive contact, urgent mental-health review, documented safety plan. [5] [11]
- Why is this window the highest-risk period? The first days of custody concentrate isolation, instability and unmet mental-health need. [5] [11]
- He smells of alcohol and is tremulous. How do you distinguish withdrawal from behavioural disturbance, and what is your management? Assess substance, timeframe and severity; treat symptomatic withdrawal; escalate to hospital if it exceeds facility capacity, because alcohol withdrawal can be life-threatening. [13]
Branch 3 — Comprehensive assessment and neurodisability
- What domains will your comprehensive entry assessment cover? Mental health, neurodisability, substance use, physical and dental, trauma and reproductive health — expect overlap. [1]
- He has prenatal alcohol exposure and learning difficulty. How do you assess for fetal alcohol spectrum disorder, and why does it matter? Coordinate formal FASD assessment; recognise the brain-based basis of behaviour; advocate for adaptation and support rather than punitive responses. The WA prevalence study found around one in three sentenced youth meet FASD criteria. [2]
- How do you screen for language disorder, and why is it commonly missed? A brief cognitive and language screen distinguishes capacity from compliance — "won't" and "can't" look identical but need different responses. [2]
Branch 4 — Consent, confidentiality and safeguarding in custody
- How do you assess his capacity to consent, given his learning difficulty? Assume a literacy and language barrier until you check; confirm understanding of what is offered, the alternatives and the consequences; document under the mature-minor framework. [16]
- What are the limits of confidentiality in a custodial setting? Share health information only for care purposes, not for security beyond what care requires; document what you share and why. [16]
- He discloses that another young person was assaulted in custody. What is your response? Treat it as a safeguarding and human-rights concern, not an internal matter — follow your child-protection pathway. [16]
Branch 5 — Release planning and advocacy
- What is the release health plan, and why does it matter? A portable summary, a named community clinician, a confirmed appointment and bridging prescriptions close the loop the mortality spike opens. [16]
- What is the evidence for the post-release mortality spike, and what drives it? The post-release period carries a markedly elevated death risk — suicide, overdose and injury dominate. Warm handoff and linkage are the preventive intervention. [17]
- What is your advocacy role beyond this young person? Advocate for diversion of vulnerable young people, the least restrictive setting, and community-based alternatives that address structural drivers rather than criminalising health need. [1] [16]
References
- [1]Borschmann R, Janca E, Carter A, Willoughby M, Hughes N, Snow K, et al. The health of adolescents in detention: a global scoping review. The Lancet Public Health, 2020.PMID 31954434
- [2]Bower C, Watkins RE, Mutch RC, Marriott R, Freeman J, Kippin NR, et al. Fetal alcohol spectrum disorder and youth justice: a prevalence study among young people sentenced to detention in Western Australia. BMJ Open, 2018.PMID 29440216
- [5]Borschmann R, Coffey C, Moran P, Hearps S, Degenhardt L, Kinner SA, et al. Self-harm in young offenders. Suicide & Life-Threatening Behavior, 2014.PMID 24773535
- [11]Casiano H, Bolton SL, Hildahl K, Katz LY, Bolton J, Sareen J A population-based study of the prevalence and correlates of self-harm in juvenile detention. PLoS One, 2016.PMID 26760497
- [13]Moore E, Indig D, Haysom L Traumatic brain injury, mental health, substance use, and offending among incarcerated young people. The Journal of Head Trauma Rehabilitation, 2014.PMID 23656964
- [16]Barnert ES, Perry R, Morris RE Juvenile incarceration and health. Academic Pediatrics, 2016.PMID 26548359
- [17]Borschmann R, Mortality After Release from Incarceration Consortium (MARIC) collaborators, Kinner SA Rates and causes of death after release from incarceration among 1 471 526 people in eight high-income and middle-income countries: an individual participant data meta-analysis. The Lancet, 2024.PMID 38614112